Omniome

Omniome

Developer of an innovative new DNA sequencing platform.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

round

$800m

Valuation: $800m

Acquisition
Total Funding000k
More about Omniome
Made with AI
Edit

Omniome operates at the cutting edge of DNA sequencing technology, leveraging advancements in nanotechnology and genomics to deliver unparalleled solutions. The company primarily serves research institutions, healthcare providers, and biotech firms that require precise and efficient DNA sequencing capabilities. Operating in the rapidly growing genomics market, Omniome's business model revolves around the development and sale of high-performance sequencing instruments and consumables. Revenue is generated through the sale of these products, as well as through service contracts and maintenance agreements. The company is known for its collaborative environment, bringing together a team of skilled scientists and engineers dedicated to pushing the boundaries of what's possible in DNA sequencing.

Keywords: DNA sequencing, nanotechnology, genomics, research institutions, healthcare, biotech, sequencing instruments, consumables, innovation, collaboration.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo